Stockscreener 앱 받기
573.38
1.09%
6.16
시간 외 거래:
572.10
-1.28
-0.22%
Regeneron Pharmaceuticals Inc 주식(REGN)의 최신 뉴스
Will Regeneron Pharmaceuticals Inc. outperform the marketMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - MSN
Regeneron Pharmaceuticals, Inc. $REGN Position Reduced by Alliancebernstein L.P. - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by AQR Capital Management LLC - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Rating Upgraded by Raymond James Financial - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN is Armistice Capital LLC's 10th Largest Position - MarketBeat
GW Henssler & Associates Ltd. Acquires 2,543 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
How to forecast Regeneron Pharmaceuticals Inc. trends using time seriesVolume Spike & Fast Exit Strategy with Risk Control - Newser
RHHBY Posts Positive Data on Vabysmo in nAMD at Euretina Congress - The Globe and Mail
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyGap Down & Stock Timing and Entry Methods - Newser
Will Regeneron Pharmaceuticals Inc. benefit from seasonalityJuly 2025 Momentum & Community Consensus Trade Signals - خودرو بانک
Amundi Buys 52,166 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Adage Capital Partners GP L.L.C. Has $58.82 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Flputnam Investment Management Co. Cuts Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Royal Bank of Canada Decreases Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (REGN): Undervalued Innovator with Asymmetric Upside in 2025–2026 - AInvest
Regeneron Pharmaceuticals, Inc. $REGN Stock Position Lessened by Vident Advisory LLC - MarketBeat
Is a relief rally coming for Regeneron Pharmaceuticals Inc. holdersM&A Rumor & Safe Entry Zone Identification - Newser
Ieq Capital LLC Raises Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Can Regeneron Pharmaceuticals Inc. expand its profit marginsDividend Hike & Free Safe Entry Trade Signal Reports - خودرو بانک
Sanofi’s amlitelimab hits phase III endpoints in atopic dermatitis - BioWorld MedTech
Landscape Capital Management L.L.C. Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron’s Strategic Visibility in Upcoming Investor Conferences: A Glimpse into Innovation and Growth - AInvest
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference - MarketScreener
Leading Biotech Regeneron Announces New Time for Morgan Stanley Global Healthcare Conference - Stock Titan
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Canada Pension Plan Investment Board - MarketBeat
Regeneron at Wells Fargo Conference: Strategic Insights on Growth - Investing.com
Transcript : Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 09 - MarketScreener
Raymond James maintains Market Outperform rating on Regeneron stock - Investing.com
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Share Price Is Matching Sentiment Around Its Earnings - 富途牛牛
Measuring Regeneron Pharmaceuticals Inc.’s beta against major indicesJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Immuno-Oncology Q2 Earnings: Regeneron (NASDAQ:REGN) Simply the Best - Yahoo Finance
Is Regeneron Pharmaceuticals Inc. on track to beat earningsJuly 2025 Catalysts & Expert Curated Trade Setups - خودرو بانک
How high can Regeneron Pharmaceuticals Inc. stock goJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Magnetar Financial LLC Sells 96,608 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Momentum divergence signals in Regeneron Pharmaceuticals Inc. chart2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Regeneron Tumbles 2.44% as 640M in Trading Volume Ranks 144th in Market Activity - AInvest
Lansforsakringar Fondforvaltning AB publ Sells 1,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Regeneron Pharmaceuticals’ Strategic Position in the 2025 Biotech Landscape - AInvest
Regeneron at Cantor Global Healthcare Conference: Strategic Growth and Challenges - Investing.com
Can Regeneron Pharmaceuticals Inc. reach all time highs this yearQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - خودرو بانک
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Sporadic Inclusion Body Myositis Market: Epidemiology, - openPR.com
The Manufacturers Life Insurance Company Purchases 41,826 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - Newser
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - Yahoo Finance
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Sector Moves & AI Enhanced Trading Alerts - Newser
Resistance Check: Can Regeneron Pharmaceuticals Inc. expand its profit marginsJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Te Ahumairangi Investment Management Ltd Makes New $896,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Orion Investment Co Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
0.34%
2.33%
자본화:
|
볼륨(24시간):